Gadobenate dimeglumine (MultiHance) has higher r1 relaxivity than gadoterate meglumine (Dotarem) which may permit the use of lower doses for MR imaging applications. Our aim was to compare 0.1- and 0.05-mmol/kg body weight gadobenate with 0.1-mmol/kg body weight gadoterate for MR imaging assessment of brain tumors.
Vaneckova, M., Herman, M., Smith, M., Mechl, M., Maravilla, K., Weichet, J., Spampinato, M., Žižka, J., Wippold, F., Baima, J., Babbel, R., Bültmann, E., Huang, R., Buhk, J., Bonafé, A., Colosimo, C., Lui, S., Kirchin, M., Shen, N., Pirovano, G., Spinazzi, A., The Benefits of High Relaxivity for Brain Tumor Imaging: Results of a Multicenter Intraindividual Crossover Comparison of Gadobenate Dimeglumine with Gadoterate Meglumine (The BENEFIT Study), <<AJNR, AMERICAN JOURNAL OF NEURORADIOLOGY>>, 2015; 36 (9): 1589-1598. [doi:10.3174/ajnr.A4468] [http://hdl.handle.net/10807/70066]
Autori: | ||
Titolo: | The Benefits of High Relaxivity for Brain Tumor Imaging: Results of a Multicenter Intraindividual Crossover Comparison of Gadobenate Dimeglumine with Gadoterate Meglumine (The BENEFIT Study) | |
Digital Object Identifier (DOI): | http://dx.doi.org/10.3174/ajnr.A4468 | |
Data di pubblicazione: | 2015 | |
Abstract: | Gadobenate dimeglumine (MultiHance) has higher r1 relaxivity than gadoterate meglumine (Dotarem) which may permit the use of lower doses for MR imaging applications. Our aim was to compare 0.1- and 0.05-mmol/kg body weight gadobenate with 0.1-mmol/kg body weight gadoterate for MR imaging assessment of brain tumors. | |
Lingua: | Inglese | |
Rivista: | ||
Citazione: | Vaneckova, M., Herman, M., Smith, M., Mechl, M., Maravilla, K., Weichet, J., Spampinato, M., Žižka, J., Wippold, F., Baima, J., Babbel, R., Bültmann, E., Huang, R., Buhk, J., Bonafé, A., Colosimo, C., Lui, S., Kirchin, M., Shen, N., Pirovano, G., Spinazzi, A., The Benefits of High Relaxivity for Brain Tumor Imaging: Results of a Multicenter Intraindividual Crossover Comparison of Gadobenate Dimeglumine with Gadoterate Meglumine (The BENEFIT Study), <<AJNR, AMERICAN JOURNAL OF NEURORADIOLOGY>>, 2015; 36 (9): 1589-1598. [doi:10.3174/ajnr.A4468] [http://hdl.handle.net/10807/70066] | |
Appare nelle tipologie: | Articolo in rivista, Nota a sentenza |